FDA warned 4 companies, which are claiming that their products containing cannabidiol, can treat or cure cancer.
Pharma maker pleads guilty that one of its major drugs was misbranded in a federal court case brought by FDA and the US Department of Justice.
FDA is advising that these 2 opioid addiction medications should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system.
FDA approved the first generic version of oseltamivir phosphate (Tamiflu, Roche) for oral suspension to treat influenza A and B, plus 2 other noteworthy therapies.
While FDA has approved a handful of biosimilar drugs, the agency just approved the first biosimilar that treats a variety of types of cancer.
An increased risk of deaths for patients in clinical trials receiving this cancer drug and two other drugs led FDA to stop the clinical trials.
A top-selling diabetes drug has gained a cardiovascular indication from FDA.
New biosimilars may harm the sales of this autoimmune blockbuster.
An FDA committee will review prescription opioid products containing hydrocodone or codeine to treat coughs in children.
FDA APPROVALS
FDA clears first opioid withdrawal device

FDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.

FDA approves first pill that can be tracked when ingested
FDA okays unique injectable for type 2 diabetics
Shingles vaccine wins approval
CLINICAL

Event Resources

 

Stay current on the latest developments in your specialty with ModernMedicine's regularly updated collection of conference briefs and webinars.